Bannari Amm.Sug. (BANARISUG)

FairStock Score: 11/100 — RISKY

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

Strengths

• Virtually debt-free balance sheet with Debt/Equity of 0.01, rare in capital-intensive sugar industry
• High promoter holding of 58.70% aligns management interests with minority shareholders
• Strong recent momentum: sales grew 52.84% and profit grew 67.96%
• Piotroski F-Score of 7/9 indicates solid near-term financial health

Concerns

• Low ROE of 8.16% and ROCE of 8.68% reflect weak capital productivity and limited pricing power in a commoditised business
• Rich valuation: P/E of 31.95 and P/B of 2.65 near the upper end of the 52-week range leaves little margin of safety
• Latest quarter net margin is thin at around 7.5% (₹48 Cr profit on ₹644 Cr sales), showing vulnerability to cost and price swings
• Dividend yield of just 0.35% means total return depends entirely on uncertain price appreciation

AI Analysis

As a value investor, I'm drawn to simple businesses, but sugar is not a simple 'wonderful' business. It is a cyclical commodity play, and Bannari Amm Sug's latest numbers reflect a cyclical upswing. Sales surged 52.84% and profit grew 67.96%, yet the market cap of ₹4,521 Cr against a P/E of 31.95 tells me much of the good news is already priced in. I pay attention to balance sheet first: with a Debt/Equity of just 0.01, this company is virtually debt-free, which is excellent in a capital-intensive sector. The book value is ₹1,379.35 per share, and at ₹3,655.10, I'm paying 2.65 times book for an ROE of only 8.16%. That is not a high-quality franchise return; a truly wonderful business earns much more on tangible capital. Promoter holding at 58.70% is reassuring, and a Piotroski F-Score of 7/9 suggests near-term financial health. However, the 52-week range of ₹3,105 to ₹3,849 shows we are near the top. Dividend yield is a negligible 0.35%, so patient shareholders get little while waiting. Sugar pricing and ethanol policy drive earnings; the latest quarter's net profit of ₹48 Cr on ₹644 Cr sales gives a thin margin. Graham would say: is there a margin of safety? At P/E 32 and P/B 2.65, I don't see it for a cyclical with 8% returns. The PEG ratio of 0.53 tempts growth seekers, but for a commodity, that growth is likely mean-reverting. I'd wait for a lower multiple or a clearer structural advantage. For now, it's a financially sound cyclical, not a Buffett franchise.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer